The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2023 | Highlights from the BTOG 2023 therapeutics symposium
Samreen Ahmed, FRCP, MD, MBBS, MSc (onc), University Hospitals of Leicester, UK & Spire Leicester Hospital, Leicester, UK, outlines the key, emerging topics covered in the therapeutics symposium at the British Thoracic Oncology Group (BTOG) Annual Conference 2023. Recent noticeable results in early-phase TILs studies were presented, on-going, collaborative trials focusing on rare mutations across various cancer types were highlighted, and the issue of co-mutations was raised. This interview took place at the BTOG Annual Conference 2023 in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
